Page last updated: 2024-08-24

fenofibric acid and Obesity

fenofibric acid has been researched along with Obesity in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Iwai, K; Kitoh, M; Maruta, K; Nagamine, J; Nagata, R; Taiji, M; Tsuchida, A; Ushiroda, K	1
Fenaux, M; Halcomb, RL; Jones, CT; Romero, FA; Xu, Y	1
Chen, G; Chen, L; Cheng, J; Gui, L; Li, C; Lu, Y; Shen, B; Zhang, Q	1
Mikhailidis, DP; Wierzbicki, AS; Wray, R	1
Ide, T; Kobayashi, N; Murakami, K; Nagasawa, M; Tsunoda, M; Utsumi, M	1

Reviews

2 review(s) available for fenofibric acid and Obesity

Article	Year
The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease. Journal of medicinal chemistry, 2020, 05-28, Volume: 63, Issue:10 Topics: Animals; Anticholesteremic Agents; Drug Delivery Systems; Drug Development; Humans; Hypoglycemic Agents; Lipid Metabolism; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Obesity; PPAR gamma; Protein Structure, Tertiary	2020
Drug treatment of combined hyperlipidemia. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2001, Volume: 1, Issue:5 Topics: Acute Disease; Clofibric Acid; Diabetes Mellitus, Type 2; Female; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemia, Familial Combined; Insulin Resistance; Liver Diseases; Obesity; Pancreatitis; Pregnancy; Pregnancy Complications	2001

Article

Year

The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease.

Journal of medicinal chemistry, 2020, 05-28, Volume: 63, Issue:10

Topics: Animals; Anticholesteremic Agents; Drug Delivery Systems; Drug Development; Humans; Hypoglycemic Agents; Lipid Metabolism; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Obesity; PPAR gamma; Protein Structure, Tertiary

2020

Drug treatment of combined hyperlipidemia.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2001, Volume: 1, Issue:5

Topics: Acute Disease; Clofibric Acid; Diabetes Mellitus, Type 2; Female; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemia, Familial Combined; Insulin Resistance; Liver Diseases; Obesity; Pancreatitis; Pregnancy; Pregnancy Complications

2001

Other Studies

3 other study(ies) available for fenofibric acid and Obesity

Article	Year
Development of a new class of benzoylpyrrole-based PPARα/γ activators. Bioorganic & medicinal chemistry letters, 2011, Jan-01, Volume: 21, Issue:1 Topics: Acetates; Animals; Carboxylic Acids; Hyperglycemia; Hypoglycemic Agents; Male; Mice; Mice, Obese; Obesity; PPAR alpha; PPAR gamma; Pyrroles; Rats; Structure-Activity Relationship	2011
Endoplasmic reticulum stress involved in high-fat diet and palmitic acid-induced vascular damages and fenofibrate intervention. Biochemical and biophysical research communications, 2015, Feb-27, Volume: 458, Issue:1 Topics: Animals; Aorta; Cells, Cultured; Diet, High-Fat; Endoplasmic Reticulum Stress; Endothelial Cells; Endothelium, Vascular; Female; Fenofibrate; Gene Expression Regulation; Lipid Metabolism; Mice; Nitric Oxide; Nitric Oxide Synthase Type III; Obesity; Palmitic Acid; Rats, Sprague-Dawley; Vasodilation	2015
A novel PPARalpha agonist ameliorates insulin resistance in dogs fed a high-fat diet. American journal of physiology. Endocrinology and metabolism, 2008, Volume: 294, Issue:5 Topics: Adiponectin; Adipose Tissue; Animals; Butyrates; Dietary Fats; DNA, Complementary; Dogs; Dose-Response Relationship, Drug; Fatty Acids; Fenofibrate; Genes, Reporter; Humans; Hypolipidemic Agents; Insulin Resistance; Lipids; Liver; Luciferases; Male; Obesity; Oxidation-Reduction; PPAR alpha; PPAR delta; PPAR gamma; Rats; Reverse Transcriptase Polymerase Chain Reaction; Transcriptional Activation	2008